课题基金 / 基金详情

IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST

IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST
白细胞介素 1 受体拮抗剂的体内功能
批准号:
2887707
负责人:
DAVID I. HIRSH
金额:
$33.33万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2003-03-31

项目摘要

项目成果

DAVID I. HIRSH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自研究者摘要):本提案旨在
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): This proposal seeks to understand the in vivo functions of endogenously expressed interleukin-1 receptor antagonist (IL-1ra). Mice lacking IL-1ra (gene knockouts) and mice over expressing IL-1ra (transgenics) will be characterized. These mutant mice to wildtype littermate controls. The proposed experiments will further analyze the underlying cellular and molecular physiological responses to the different levels of IL-1ra expression that occur in these mice. Changes in cytokine profiles will be analyzed as will leukocyte proliferation and migration. These studies will provide a deeper understanding of the in vivo mechanisms that respond to IL-1ra and provide clear phenotypes that can be used as genetic markers in a set of epistasis experiments. Double and triple mutants will be constructed involving the IL-1ra knockouts and overexpressors, IL-1 receptor nulls, IL-1beta TAbetas114 knockouts and caspase-1 (ICE) knockouts, in order to define the interactions between members of the IL-1/IL-1ra pathway. These epistasis experiments are intended to determine which phenotypes are due to the intracellular versus the secreted forms of IL-1ra, and to resolve whether another target exists for IL-1ra in addition to the IL-1 receptor, which the phenotypes of the single mutants currently strongly suggest.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LABORATORIES FOR RESEARCH IN PARKINSON'S DISEASE
IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST
IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST
IN VIVO FUNCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST
海外基金